TRIPHED Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Triphed, and when can generic versions of Triphed launch?
Triphed is a drug marketed by Teva and is included in one NDA.
The generic ingredient in TRIPHED is pseudoephedrine hydrochloride; triprolidine hydrochloride. There are forty-nine drug master file entries for this compound. Additional details are available on the pseudoephedrine hydrochloride; triprolidine hydrochloride profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for TRIPHED?
- What are the global sales for TRIPHED?
- What is Average Wholesale Price for TRIPHED?
Summary for TRIPHED
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 33 |
| Patent Applications: | 5,340 |
| DailyMed Link: | TRIPHED at DailyMed |
US Patents and Regulatory Information for TRIPHED
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Teva | TRIPHED | pseudoephedrine hydrochloride; triprolidine hydrochloride | TABLET;ORAL | 088630-001 | May 17, 1984 | DISCN | No | No | ⤷ Subscribe | ⤷ Subscribe | ⤷ Subscribe | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
